SMN1 and liver disorder: ‐Failure of HSC activation (↓α‐SMA, ↓col)‐Reduced hepatocyte proliferation (in vivo and in vitro)‐2/3 reduction of HGF in liver homogenates‐More severe liver disease and reduced survival